|
Index of reports
> Cases resulting in hospitalization (69)
> Cases with Weight Decreased (8)
Below is the selection of adverse event reports related to Amaryl (Glimepiride) that includes cases resulting in hospitalization where reactions include weight decreased.
Adverse event in 69 year old female receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-07-03
Patient: 69 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Weight Decreased, White Blood Cell Count Decreased, Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Monocyte Count Increased, Hypokalaemia, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Blood Sodium Increased, Oedema, Platelet Count Decreased, Muscle Spasms
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Diovan
Dosage: 80 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Fluitran
Dosage: 2 mg/day
Administration route: Oral
Indication: Oedema
End date: 2007-03-19
Glycyron
Dosage: 3 df/day
Administration route: Oral
Indication: Hepatic Cirrhosis
End date: 2007-03-19
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Norvasc
Start date: 2007-04-04
Other drugs received by patient: Aldactone
Adverse event in 69 year old female receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-06-06
Patient: 69 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Weight Decreased, White Blood Cell Count Decreased, Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Monocyte Count Increased, Hypokalaemia, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Blood Sodium Increased, Oedema, Platelet Count Decreased, Muscle Spasms
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Diovan
Dosage: 80 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Fluitran
Dosage: 2 mg/day
Administration route: Oral
Indication: Oedema
End date: 2007-03-19
Glycyron
Dosage: 3 df/day
Administration route: Oral
Indication: Hepatic Cirrhosis
End date: 2007-03-19
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Norvasc
Start date: 2007-04-04
Other drugs received by patient: Aldactone
Adverse event in 69 year old female receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-05-23
Patient: 69 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Weight Decreased, White Blood Cell Count Decreased, Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Monocyte Count Increased, Muscle Twitching, Hypokalaemia, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Oedema, Blood Sodium Increased, Platelet Count Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Diovan
Dosage: 80 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Fluitran
Dosage: 2 mg/day
Administration route: Oral
Indication: Oedema
End date: 2007-03-19
Glycyron
Dosage: 3 df/day
Administration route: Oral
Indication: Hepatic Cirrhosis
End date: 2007-03-19
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Norvasc
Start date: 2007-04-04
Other drugs received by patient: Aldactone
Adverse event in receiving Amaryl (Glimepiride)
Reported by a consumer/non-health professional from France on 2007-05-04
Patient:
Adverse reactions / side effects: Weight Decreased, Pruritus
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 10 mg, qd
Administration route: Oral
Amaryl
Dosage: 2 mg, qd
Administration route: Oral
Cardensiel
Dosage: 10 mg, qd
Administration route: Oral
Lasilix / 00032601 /
Dosage: 60 mg, qd
Administration route: Oral
Previscan / 00789001 /
Dosage: unk, unk
Administration route: Oral
Tahor
Dosage: 10 mg, qd
Administration route: Oral
Adverse event in 73 year old female receiving Amaryl (Glimepiride)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-30
Patient: 73 year old female
Adverse reactions / side effects: Weight Decreased, Pruritus, Cardiac Pacemaker Insertion, Anorexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Administration route: Oral
Cardensiel
Administration route: Oral
Lasix
Dosage: daily dose:60mg
Administration route: Oral
Previscan
Administration route: Oral
Tahor
Administration route: Oral
Triatec
Administration route: Oral
Adverse event in 73 year old female receiving Amaryl (Glimepiride)
Reported by a individual with unspecified qualification from France on 2007-04-27
Patient: 73 year old female
Adverse reactions / side effects: Weight Decreased, Pruritus
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: 2 mg (2 mg, 1 d); oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Atorvastatin Calcium
Dosage: 10 mg (10 mg, 1 d); oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Bisoprolol Fumarate
Dosage: 10 mg (10 mg, 1 d); oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Lasix
Dosage: 1.5 dosage forms (1,5 dosage forms, 1 d); oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Previscan (20 MG, Tablet) (Fluindione)
Dosage: oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Ramipril
Dosage: 10 mg (5 mg, 2 in 1 d); oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in 73 year old female receiving Amaryl (Glimepiride)
Reported by a individual with unspecified qualification on 2007-04-26
Patient: 73 year old female
Adverse reactions / side effects: Weight Decreased, Pruritus
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Cardensiel
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Lasilix / 00032601 /
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Previscan / 00789001 /
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Tahor
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Triatec / 00885601 /
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in 73 year old female receiving Amaryl (Glimepiride)
Reported by a individual with unspecified qualification on 2007-04-26
Patient: 73 year old female
Adverse reactions / side effects: Weight Decreased, Pruritus
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Cardensiel
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Lasilix / 00032601 /
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Previscan / 00789001 /
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Tahor
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Triatec / 00885601 /
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
|
